Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic Neuralgia

This study has been completed.
Information provided by:
Allergan Identifier:
First received: September 12, 2005
Last updated: May 27, 2011
Last verified: May 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2005
  Primary Completion Date: June 2005 (Final data collection date for primary outcome measure)